Agonistic anti-ICAM-1 antibodies in scleroderma: Activation of endothelial pro-inflammatory cascades

Vascular Pharmacology

Volumn 59, Issue 1-2, 2013, Pages 19-26

  Wolf, Sabine I ^a   Howat, Sarah ^b   Abraham, David J ^c   Pearson, Jeremy D ^b   Lawson, Charlotte ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Autoantibodies; ICAM 1; Systemic sclerosis; Vascular inflammation

Indexed keywords

ENDOTHELIAL CELL ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; REACTIVE OXYGEN METABOLITE; RECOMBINANT INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; BIOSYNTHESIS; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; SCLERODERMA; UMBILICAL VEIN ENDOTHELIAL CELL;

AUTOANTIBODIES; ICAM-1; SYSTEMIC SCLEROSIS; VASCULAR INFLAMMATION;

ANTIBODIES; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CELLS, CULTURED; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; REACTIVE OXYGEN SPECIES; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84880696944     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2013.05.002     Document Type: Article

References (35)

1. Ahmed S.S., Tan F.K., et al. Induction of apoptosis and fibrillin 1 expression in human dermal endothelial cells by scleroderma sera containing anti-endothelial cell antibodies. Arthritis Rheum. 2006, 54(7):2250-2262.
2. Alessandri C., Bombardieri M., et al. Pathogenic mechanisms of anti-endothelial cell antibodies (AECA): their prevalence and clinical relevance. Adv. Clin. Chem. 2006, 42:297-326.
3. Amos C., Romero I.A., et al. Cross-linking of brain endothelial intercellular adhesion molecule (ICAM)-1 induces association of ICAM-1 with detergent-insoluble cytoskeletal fraction. Arterioscler. Thromb. Vasc. Biol. 2001, 21(5):810-816.
4. Carvalho D., Savage C.O., et al. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J. Clin. Invest. 1996, 97(1):111-119.
5. Cavazzana I., Angela C., et al. Anti-RNA polymerase III antibodies: a marker of systemic sclerosis with rapid onset and skin thickening progression. Autoimmun. Rev. 2009, 8(7):580-584.
6. Constans J., Dupuy R., et al. Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus. J. Rheumatol. 2003, 30(9):1963-1966.
7. Del Papa N., Guidali L., et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum. 1996, 39(5):758-766.
8. Etienne S., Adamson P., et al. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J. Immunol. 1998, 161(10):5755-5761.
9. Farsi A., Domeneghetti M.P., et al. Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. Atherosclerosis 2001, 154(2):429-436.
10. Fredrich R., Toyoda M., et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 1999, 67(3):385-391.
11. Gabrielli A., Svegliati S., et al. Pathogenic autoantibodies in systemic sclerosis. Curr. Opin. Immunol. 2007, 19(6):640-645.
12. Hasegawa M., Fujimoto M., et al. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J. Rheumatol. 1997, 24(2):328-332.
13. Hasegawa M., Sato S., et al. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. J. Rheumatol. 1998, 25(2):308-313.
14. Henderson L.M., Chappell J.B. Dihydrorhodamine 123: a fluorescent probe for superoxide generation?. Eur. J. Biochem. 1993, 217(3):973-980.
15. Hernandez N.M., Casselbrant A., et al. Antibodies to kidney endothelial cells contribute to a "leaky" glomerular barrier in patients with chronic kidney diseases. Am. J. Physiol. Ren. Physiol. 2012, 302(7):F884-F894.
16. Holder A.L., Wolf S., et al. Expression of endothelial intercellular adhesion molecule-1 is determined by genotype: effects on efficiency of leukocyte adhesion to human endothelial cells. Hum. Immunol. 2008, 69(2):71-78.
17. Holmen C., Elsheikh E., et al. Anti endothelial cell autoantibodies selectively activate SAPK/JNK signalling in Wegener's granulomatosis. J. Am. Soc. Nephrol. 2007, 18(9):2497-2508.
18. Hubbard A.K., Rothlein R. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Radic. Biol. Med. 2000, 28(9):1379-1386.
19. Ihn H., Sato S., et al. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines. Br. J. Rheumatol. 1997, 36(12):1270-1275.
20. Ihn H., Sato S., et al. Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): association with pulmonary fibrosis. Clin. Exp. Immunol. 2000, 119(1):203-209.
21. Kao L., Weyand C. Vasculitis in systemic sclerosis. Int. J. Rheumatol. 2010, 385938. (2010).
22. Koyama Y., Tanaka Y., et al. Cross-linking of intercellular adhesion molecule 1 (CD54) induces AP-1 activation and IL-1beta transcription. J. Immunol. 1996, 157(11):5097-5103.
23. Lawson C., Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol. Rep. 2009, 61(1):22-32.
24. Lawson C., Ainsworth M., et al. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-kappaB-independent mechanism. J. Immunol. 1999, 162(5):2990-2996.
25. Lawson C., Ainsworth M.E., et al. Effects of cross-linking ICAM-1 on the surface of human vascular smooth muscle cells: induction of VCAM-1 but no proliferation. Cardiovasc. Res. 2001, 50(3):547-555.
26. Lawson C., Holder A.L., et al. Anti-intercellular adhesion molecule-1 antibodies in sera of heart transplant recipients: a role in endothelial cell activation. Transplantation 2005, 80(2):264-271.
27. Majewski S., Hunzelmann N., et al. Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J. Investig. Dermatol. 1991, 97(4):667-671.
28. Mihai C., Tervaert J.W. Anti-endothelial cell antibodies in systemic sclerosis. Ann. Rheum. Dis. 2010, 69(2):319-324.
29. Moroi Y., Peebles C., et al. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc. Natl. Acad. Sci. U. S. A. 1980, 77(3):1627-1631.
30. Salih A.M., Nixon N.B., et al. Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by peripheral neuropathy. J. Rheumatol. 1999, 26(3):551-555.
31. Sambo P., Baroni S.S., et al. Oxidative stress in scleroderma: maintenance of scleroderma fibroblast phenotype by the constitutive up-regulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum. 2001, 44(11):2653-2664.
32. Sano H., Nakagawa N., et al. Cross-linking of intercellular adhesion molecule-1 induces interleukin-8 and RANTES production through the activation of MAP kinases in human vascular endothelial cells. Biochem. Biophys. Res. Commun. 1998, 250(3):694-698.
33. Sato S., Fujimoto M., et al. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum. 2004, 50(6):1918-1927.
34. Schmid E., Muller T.H., et al. Signaling by E-selectin and ICAM-1 induces endothelial tissue factor production via autocrine secretion of platelet-activating factor and tumor necrosis factor alpha. J. Interferon Cytokine Res. 1995, 15(9):819-825.
35. Xia Y., Kellems R.E. Receptor-activating autoantibodies and disease: preeclampsia and beyond. Expert. Rev. Clin. Immunol. 2011, 7(5):659-674.